An Integrated Strategy to Identify Tyrosine Sulfation from the Therapeutic Proteins
Journal of the American Society for Mass Spectrometry · 2024
DOI: 10.1021/jasms.4c00303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2024. Verfasst von Eunju Jang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Protein Sciences, Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States. Hauptthemen laut MEDLINE: Tyrosine, Protein Processing, Post-Translational. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Protein Sciences, Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States.
- Discovery Analytical Research, Analytical Enabling Capabilities, Merck & Co., Inc., South San Francisco, California 94080, United States.
ORCID-Profile: Fengfei Ma
Zitieren
APA
Jang, E., Ma, F., Tomazela, D., Fayadat-Dilman, L., & Al-Sayah, M. A. (2024). An Integrated Strategy to Identify Tyrosine Sulfation from the Therapeutic Proteins. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00303
Vancouver
Jang E, Ma F, Tomazela D, Fayadat-Dilman L, Al-Sayah MA. An Integrated Strategy to Identify Tyrosine Sulfation from the Therapeutic Proteins. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.4c00303
BibTeX
@article{Jang2024,
author = {Jang, Eunju and Ma, Fengfei and Tomazela, Daniela and Fayadat-Dilman, Laurence and Al-Sayah, Mohammad Ahmed},
title = {An Integrated Strategy to Identify Tyrosine Sulfation from the Therapeutic Proteins},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2024},
doi = {10.1021/jasms.4c00303}
}
EUVIMED